WASHINGTON, DC – The Center for Strategic and International Studies (CSIS), a bipartisan, nonprofit policy research organization dedicated to advancing practical ideas to address the world’s greatest ...

State Bank of India, Shriram Finance, Titan, Dr Reddy's Laboratories and Grasim Industries were among top gainers on the ...

HYDERABAD, (IANS) – In a setback for Jhansi Reddy, a member of the Congress party, her application for Indian citizenship has been denied by Indian authorities. Jhansi Reddy, who holds American ...

Hyderabad: Chief minister A Revanth Reddy on Sunday began an executive education programme at Harvard University's Kennedy School in Cambridge, Massachusetts, marking a rare academic engagement by a ...

An exercise-driven course on Advanced Python Programming that was battle-tested several hundred times on the corporate-training circuit for more than a decade. Written by David Beazley, author of the ...

Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...

Dr. Reddy’s Laboratories is paying $20 million upfront for the rights to Immutep’s phase 3-stage LAG-3 candidate in certain territories while leaving the Australian biotech with ownership in key ...

Last month, the United States and Saudi Arabia signed the Strategic Artificial Intelligence Partnership. On the heels of a May 2025 agreement with the United Arab Emirates (UAE), the United States has ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AAR's $78M acquisition of HAECO ...

Dr. Reddy’s Laboratories remains a compelling buy due to underappreciated growth in biosimilars and GLP-1 segments, despite near-term headwinds. RDY's Q2 FY26 results showed modest revenue growth, ...